Overview of China’s R&D Spending Surge

In 2024, the Organisation for Economic Co-operation and Development (OECD) reported that China’s research and development (R&D) expenditure surpassed the United States for the first time when measured in Purchasing Power Parity (PPP) terms, crossing the $1 trillion threshold. This milestone marks a significant realignment in global scientific leadership, reflecting China’s rapid ascent from a low R&D base in 1980 to becoming the world’s largest R&D investor. Concurrently, China filed approximately 1.8 million patents in 2024, nearly triple the US’s 603,000 patents, indicating a robust innovation ecosystem driven by state-led strategic investments.

China’s R&D Growth Trajectory and Policy Framework

China’s R&D spending was negligible in 1980, ranking among the lowest globally. Since then, the Chinese government has implemented systematic, state-driven investments and strategic policy frameworks, such as the National Medium- and Long-Term Program for Science and Technology Development (2006-2020), to build a comprehensive innovation ecosystem. The Chinese Academy of Sciences (CAS) plays a central role in coordinating research efforts, while state funding prioritizes both basic and applied sciences, fostering rapid commercialization and patenting activities.

• China’s R&D spending crossed $1 trillion in 2024 (OECD, 2024), overtaking the US in PPP terms.
• Patent filings reached ~1.8 million in 2024, indicating strong innovation output (WIPO, 2024).
• China leads in total scientific publications and top 1% highly cited papers (Scopus, Nature Index).
• State-led coordination enables targeted investments in emerging technologies such as AI, quantum computing, and biotechnology.

US Scientific Leadership: Historical Context and Current Challenges

The United States historically led global scientific innovation, pioneering technologies like the internet, mRNA vaccines, semiconductors, and GPS. This leadership was underpinned by a hybrid funding model combining strong federal investment in basic research with a vibrant private sector driving applied R&D. However, US federal R&D spending as a percentage of GDP declined from 1.86% in 1964 to approximately 0.66% in 2021, shifting the funding burden to private enterprises focused on commercial development rather than open science.

• Federal R&D funding decline reduced support for basic, open research critical for long-term innovation (NSF, 2023).
• Private sector accounts for ~78% of US R&D but prioritizes short-term commercial gains.
• US scientific research contributed over 20% to productivity growth since World War II, highlighting innovation’s economic impact.
• Policy constraints and geopolitical tensions have complicated US-China scientific collaboration.

Comparative Analysis: China vs. US R&D Ecosystems

Institutional and Legal Frameworks Influencing R&D

China’s rise is supported by centralized institutions like the Chinese Academy of Sciences and policy instruments that direct funding and human capital towards priority sectors. In contrast, the US relies on institutions such as the National Science Foundation (NSF) and the National Institutes of Health (NIH) to fund fundamental research, with significant private sector participation. Globally, frameworks like the WTO’s TRIPS Agreement (1994) regulate intellectual property rights, influencing patent regimes and innovation incentives in both countries and beyond.

• India’s Science and Technology Policy (2013) and National Policy on Science, Technology and Innovation (2020) aim to strengthen domestic R&D but face challenges matching China’s scale and coordination.
• International patent regimes under TRIPS affect global technology transfer and innovation diffusion.
• OECD provides authoritative data enabling cross-country R&D comparisons.

Critical Gaps in Global Perceptions of Innovation Leadership

Many analysts underestimate the role of coordinated state policy and long-term strategic investment in China’s innovation ecosystem. The focus on nominal R&D spending obscures the importance of PPP adjustments and output quality. Furthermore, patent quantity alone does not fully capture innovation quality; however, China’s leadership in highly cited scientific papers confirms substantive advances. The US’s declining federal investment and shift towards private sector-led development have reduced its dominance in open scientific knowledge creation.

Implications for India’s Science and Technology Policy

India’s R&D spending remains below 1% of GDP, far less than China’s 2.5% estimate. India’s policy frameworks emphasize innovation but lack the scale and coordination seen in China. Understanding the global shift requires India to consider:

• Enhancing public investment in basic and applied research through institutions like the Department of Science and Technology (DST).
• Balancing private sector involvement with strong public funding to sustain open scientific research.
• Strengthening intellectual property regimes aligned with TRIPS to incentivize innovation.
• Fostering international collaborations while safeguarding strategic technological domains.

Way Forward

• India must increase R&D expenditure to at least 2% of GDP with targeted funding for emerging technologies.
• Develop institutional mechanisms to coordinate research across academia, industry, and government, inspired by China’s model.
• Promote patent quality alongside quantity by incentivizing high-impact research and commercialization.
• Leverage international frameworks and partnerships to access global innovation networks.
• Prioritize STEM education and skill development to build human capital for sustained innovation.

Jharkhand & JPSC Relevance

• JPSC Paper: Paper 3 – Science and Technology, Economic Development
• Jharkhand Angle: Jharkhand’s growing industrial base and educational institutions can leverage increased R&D investments to boost regional innovation.
• Mains Pointer: Frame answers highlighting the need for state-level coordination in R&D, drawing lessons from China’s model for Jharkhand’s scientific infrastructure development.